Stockreport

Moleculin announces efficacy results from trial of Annamycin for STS lung mets [Yahoo! Finance]

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors
PDF The Phase IB in this open-label, multi-centre trial aims to determine the maximum tolerable dose and recommended Phase II dose, as well as assess the safety. Phase II f [Read more]